Finished
Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate Reconstruction
NCT04108117 · Severance Hospital · Updated 11 Sept 2023
- What is being tested
- Robotic nipple sparing mastectomy
- For
- Postoperative Complications; Recurrence; Breast Neoplasms; Breast Cancer; BRCA1 Mutation; BRCA2 Mutation; Surgery; Surgery--Complications
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 659 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 14 May 2020, ends 18 May 2022. Registered 27 Sept 2019.
- Results
- None posted yet.
In the researchers' words
Robotic mastectomy with immediate reconstruction was introduced by Toesca et al. in 2015. Since then, several studies have reported the safety and feasibility of robotic nipple-sparing mastectomy with immediate reconstruction. However, most studies were conducted by single centers and had small samples. Furthermore, there is a lack of studies comparing surgical and oncologic outcomes between robotic nipple-sparing mastectomy and conventional nipple-sparing mastectomy. For this reason, this study evaluates surgical and oncologic outcomes of robotic nipple-sparing mastectomy with immediate reconstruction using international multi-center data.
Sites
- Yonsei University College of MedicineSeoul, South Korea